Clinical Ovarian Cancer

Aims & Scope

Cessation

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian Carcinoma

  Citation: 20

  Authors: Neil S., Richard T., Dan G., Emmanuelle, Yves, Marek, Kenneth S., Suzanne, Carolyn N., Marsha A., Rakesh K.

• HER2 Overexpression/Amplification and Trastuzumab Treatment in Advanced Ovarian Cancer: A GINECO Phase II Study

  Citation: 16

  Authors: Isabelle, Jean Paul, Djelila, Martin, Béatrice, J., Hervé, S., Désiré, Mireille, Eric

• Is Serum Albumin an Independent Predictor of Survival in Ovarian Cancer?

  Citation: 10

  Authors: Digant, Carolyn A., Pankaj G., Sadie, James F., Christopher G.

• The 45th Annual Meeting of the American Society of Clinical Oncology Orlando, FL; May 29 – June 2, 2009

  Citation: 9

  Authors: Marissa, Aarati, J. Tate

• PRO: Patients at High Risk for Ovarian Cancer Should Undergo Routine Screening

  Citation: 9

  Authors: Beth Y.

• Platelet-Derived Growth Factor Pathway Inhibitors in Ovarian Cancer

  Citation: 6

  Authors: Jordan, Daniela

• Successful Treatment of Metastatic Squamous Cell Carcinoma of the Ovary Arising Within a Mature Cystic Teratoma

  Citation: 6

  Authors: Tyler C., Patrick F.

• Making of a Phase III Study in Recurrent Ovarian Cancer: The Odyssey of GOG 213

  Citation: 5

  Authors: Robert L.

• A Phase I/II Study of Lapatinib Plus Carboplatin and Paclitaxel in Relapsed Ovarian and Breast Cancer

  Citation: 5

  Authors: Saul E., Carolyn, Judith A., James, Desiree, Jane, Heather

• PRO: Patients With Metastatic/Recurrent Cervical Cancer Should be Treated With Cisplatin Plus Paclitaxel

  Citation: 5

  Authors: Krishnansu S.